Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2014 07:00 ET | Source: Ressources Cartier Inc.

Cartier vend sa propriété Diego à Standard Graphite

VAL-D'OR, QUÉBEC--(Marketwired - 20 nov. 2014) - Ressources Cartier Inc. (TSX CROISSANCE:ECR) (« Cartier ») annonce la vente à Standard Graphite Corporation («...
November 20, 2014 07:00 ET | Source: Cartier Resources Inc.

Cartier Sells the Diego Property to Standard Graphite

VAL-D'OR, QUEBEC--(Marketwired - Nov. 20, 2014) - Cartier Resources Inc. (TSX VENTURE:ECR) ("Cartier") announces the sale to Standard Graphite Corporation ("Standard Graphite") of its...
November 19, 2014 15:00 ET | Source: DIAGNOS inc.

DIAGNOS annonce le départ d'un membre de son conseil d'administration

BROSSARD, QUÉBEC--(Marketwired - 19 nov. 2014) - DIAGNOS inc. (« DIAGNOS » ou la « Société ») (TSX CROISSANCE:ADK), un leader dans les services...
November 19, 2014 15:00 ET | Source: DIAGNOS Inc.

DIAGNOS Announces Resignation to the Board of Directors

BROSSARD, QUEBEC--(Marketwired - Nov. 19, 2014) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), leader in healthcare technical services including screening, software...
November 19, 2014 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basileas Krebsmedikamentenkandidat BAL101553 induziert erhebliche Antitumorwirkung in behandlungsresistenten Tumormodellen

Daten zur Wirksamkeit von BAL101553 in behandlungsresistenten Tumormodellen, sowohl alleine als auch in Kombination mit Strahlentherapie, präsentiert auf EORTC-NCI-AACR-Symposium* BAL101553...
November 19, 2014 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea's oncology drug candidate BAL101553 induces significant anti-tumor effect in treatment-refractory tumor models

BAL101553 anti-cancer activity in treatment-refractory cancer models, alone and in combination with radiotherapy, presented at EORTC-NCI-AACR Symposium* BAL101553 has anti-tumor activity when...
November 18, 2014 08:04 ET | Source: MorphoSys AG

MorphoSys to Present at Two Upcoming Investor Conferences

MARTINSRIED / MUNICH, Germany, Nov. 18, 2014 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following investor conferences in...
November 18, 2014 07:00 ET | Source: Black Iron Inc.

Black Iron Provides Corporate Update and Welcomes Les Kwasik as COO

TORONTO, ONTARIO--(Marketwired - Nov. 18, 2014) - Black Iron Inc. ("Black Iron" or the "Company") (TSX:BKI)(FRANKFURT:BIN) is pleased to announce the appointment of Les Kwasik as Chief...
November 17, 2014 12:40 ET | Source: Nemaska Lithium Inc.

Nemaska Lithium clôture un financement de 1 542 5000 $

QUÉBEC, QUÉBEC--(Marketwired - 17 nov. 2014) - CE COMMUNIQUÉ NE DOIT PAS ÊTRE DIFFUSÉ, PUBLIÉ OU DISTRIBUÉ, EN TOUT OU EN PARTIE, AUX...
November 17, 2014 12:39 ET | Source: Nemaska Lithium Inc.

Nemaska Lithium Financing Oversubscribed at $1,542,500

QUÉBEC, QUÉBEC--(Marketwired - Nov. 17, 2014) - THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. WIRE NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ...